Michael Dattoli Offers a New Therapeutic Agent for Advanced Prostate Cancer
This week Dattoli Cancer Center & Brachytherapy Research Institute became the first independent physician practice in the U.S. to offer men with advanced metastatic prostate cancer an injectable isotope of radium, marketed by Bayer as Xofigo® (zoh-fee-go). This new pharmaceutical was recently FDA approved for use in men with castration-resistant...